Tandem Diabetes Care delivered a stronger-than-expected 4Q performance, driven by a 67% jump in its global pump shipments. Shares of the insulin delivery …
Oppenheimer’s Steven Lichtman now bets on 6% in return potential for TNDM stock, with eyes on a new driver: a forthcoming international launch.
Tandem Diabetes Care Inc (NASDAQ:TNDM) hit a preliminary home run with its first quarter earnings show for 2018, releasing an exciting revenue beat …
Investors are racing to buy Tandem Diabetes Care Inc (NASDAQ:TNDM) shares, after the insulin pump maker announced FDA approval and commercial launch of the t:slim …